Prior bariatric surgery (prior-BS) in type 2 diabetes mellitus (T2DM) patients undergoing noncardiac surgery is associated with a lower risk of major adverse cardiovascular and cerebrovascular events (MACCEs), according to researchers from The First Affiliated Hospital, Sun Yat-Sen University, South China University of Technology, Guangzhou and the Second Military Medical University, Shanghai, China.

IFSO Endoscopy Committee has published a Position Statement on the best practise of bariatric endoscopy in response to the CVOID-19 pandemic. The statement offers guidance on navigating bariatric endoscopic procedures in patients with obesity during the COVID-19 pandemic, in the hope of mitigating the risk of SARS-CoV-2 transmission to vulnerable patients and healthcare workers. The statement acknowledges that the recommendations may evolve as the pandemic progresses.

African American (AA) patients undergoing bariatric surgery are younger and heavier than non-AA patients, present with different comorbidity profiles and exhibit worse outcomes following Roux-en-Y gastric bypass (RYGB) or sleeve gastrectomy (SG) than non-AA patients, including increased mortality rates in AA-SG patients.

Breast cancer patients who are overweight or have obesity might benefit less from treatment with docetaxel, a common chemotherapy drug, than lean patients, according to an international team of researchers who carried out a retrospective analysis of data from a large clinical trial.